Characterization of porphyrin heme oxygenase inhibitors

Canadian Journal of Physiology and Pharmacology

Volumn 74, Issue 3, 1996, Pages 278-285

  Vreman, Hendrik J ^a   Cipkala, Douglas A ^a   Stevenson, David K ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Carbon monoxide; Heme oxygenase; Metalloporphyrin; Neonatal jaundice; Photoreactivity

Indexed keywords

HEME OXYGENASE; METALLOPORPHYRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; JAUNDICE; LIVER; MALE; NONHUMAN; PHOTOREACTIVITY; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN; ENZYME INHIBITORS; HEME OXYGENASE (DECYCLIZING); HEMOLYSIS; LIVER; MALE; METALLOPORPHYRINS; MOLECULAR STRUCTURE; RATS; RATS, WISTAR; SPLEEN;

EID: 0029950043     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/cjpp-74-3-278     Document Type: Article

References (47)

1. Bartoletti, A.L., Stevenson, D.K., Ostrander, C.R., and Johnson, J.D. 1979. Pulmonary excretion of carbon monoxide in the human infant as an index of bilirubin production. I. Effects of gestational and postnatal age and some common neonatal abnormalities. Pediatrics, 94: 952-955.
2. Brune, B., and Ullrich, V. 1992. Cyclic nucleotides and intracellular-calcium homeostasis in human platelets. Eur. J. Biochem. 207(2): 607-613.
3. Chernick, R.J., Martasek, P., Levere, R.D., Margreiter, R., and Abraham, N.G. 1989. Sensitivity of human tissue heme oxygenase to a new synthetic metalloporphyrin. Hepatology, 10: 365-369.
4. Dawson, T.M., and Snyder, S.H. 1994. Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J. Neurosci. 14: 5147-5159.
5. Dennery, P.A., Rhine, W.D., and Stevenson, D.K. 1995. Neonatal jaundice - What now? Clin. Pediatr. 34: 103-107.
6. Drummond, G.S., and Kappas, A. 1981. Prevention of neonatal hyperbilirubinemia by tin protoporphyrin IX, a potent competitive inhibitor of heme oxidation. Proc. Natl. Acad. Sci. U.S.A. 78: 6466-6470.
7. Drummond, G.S., and Kappas, A. 1982. Suppression of hyperbilirubinemia in the rat neonate by chromium-protoporphyrin. Interactions of metalloporphyrins with microsomal heme oxygenase of human spleen. J. Exp. Med. 156: 1878-1883.
8. Drummond, G.S., and Kappas, A. 1986. Sn-protoporphyrin of fetal and neonatal brain heme oxygenase. Transplacental passage of the metalloporphyrin and prenatal suppression of hyperbilirubinemia in the newborn animal. J. Clin. Invest. 77: 971-976.
9. Frydman, R.B., Tomaro, M.L., Buldain, G., Awruch, J., Diaz, L., and Frydman, B. 1981. Specificity of heme oxygenase: a study with synthetic hemins. Biochemistry, 20: 5177-5182.
10. Galbraith, R.A., and Kappas, A. 1989. Regulation of food intake and body weight by cobalt porphyrins in animals. Proc. Natl. Acad. Sci. U.S.A. 86: 7653-7657.
11. Greenbaum, N.L., and Kappas, A. 1994. Distribution of metalloporphyrin inhibitors of heme oxygenase among serum transport proteins. Pharmacology, 49: 205-214.
12. Hintz, S.R., Vreman, H.J., and Stevenson, D.K. 1990. Mortality of metalloporphyrin-treated neonatal rats after light exposure. Dev. Pharmacol. Ther. 14: 187-192.
13. Ignarro, L.J., Ballot, B., and Wood, K.S. 1984. Regulation of soluble guanylate cyclase activity by porphyrins and metalloporphyrins. J. Biol. Chem. 259: 6201-6207.
14. Kappas, A., Drummond, G.S., Manola, T., Petmezaki, S., and Valaes, T. 1988. Sn-protoporphyrin use in the management of hyperbilirubinemia in term newborns with direct Coombs-positive ABO incompatibility. Pediatrics, 81: 485-497.
15. Land, E.J., McDonagh, A.F., McGarvey, D.J., and Truscott, T.G. 1988. Photophysical studies of tin(IV)-protoporphyrin: potential phototoxicity of a chemotherapeutic agent proposed for the prevention of neonatal jaundice. Proc. Natl. Acad. Sci. U.S.A. 85: 5249-5253.
16. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
17. Lucey, J.F. 1982. Bilirubin and brain damage - a real mess. Pediatrics, 69: 381-382.
18. Maines, M.D. 1981. Zinc-protoporphyrin is a selective inhibitor of heme oxygenase activity in the neonatal rat. Biochim. Biophys. Acta, 673: 339-350.
19. Maines, M.D. 1988. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J. 2: 2557-2568.
20. Maines, M.D. 1992. Heme oxygenase: clinical applications and functions. CRC Press Inc., Boca Raton, Fia. pp. 1-276.
21. Maines, M.D., and Trakshel, G.M. 1992a. Tin-protoporphyrin: a potent inhibitor of hemoprotein-dependent steroidogenesis in rat adrenals and testes. Pharmacol. Exp. Ther. 260: 909-916.
22. Maines, M.D., and Trakshel, G.M. 1992b. Differential regulation of heme oxygenase isozymes by Sn- and Zn-protoporphyrins: possible relevance to suppression of hyperbilirubinemia. Biochim. Biophys. Acta, 1131: 166-174.
23. Maisels, M.J. 1988. Neonatal jaundice. Semin. Liver Dis. 8: 148-162.
24. Maisels, M.J., Pathak, A., Nelson, N.M., Nathan, D.G., and Smith, C.A. 1971. Endogenous production of carbon monoxide in normal and erythroblastotic newborn infants. J. Clin. Invest. 50: 1-7.
25. Marks, G.S., Brien, J.F., Nakatsu, K., and McLaughlin, B.E. 1991. Does carbon monoxide have a physiological function? Trends Pharmacol. Sci. 12: 185-188.
26. Meffert, M.K., Haley, J.E., Schuman, E.M., Schulman, H., and Madison, D.V. 1994. Inhibition of hippocampal heme oxygenase, nitric oxide synthase, and long-term potentiation by metalloporphyrins. Neuron, 13: 1225-1233.
27. Monta, T., Perrella, M.A., Lee, M.E., and Kourembanas, S. 1995. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc. Natl. Acad. Sci. U.S.A. 92: 1475-1479.
28. Ostrow, J.D. 1988. Therapeutic amelioration of jaundice: old and new strategies. Hepatology, 8: 683-689.
29. Penn, A.A., Enzmann, D.R., Hahn, J.S., and Stevenson, D.K. 1994. Kernicterus in a full term infant. Pediatrics, 93: 1003-1006.
30. Polin, R.A. 1990. Management of neonatal hyperbilirubinemia: rational use of phototherapy. Biol. Neonate, 58: 32-43.
31. Schmidt, H.H.W. 1992. NO, CO, and OH. Endogenous soluble guanylyl cyclase-activating factors. FEBS Lett. 307: 102-107.
32. Slusher, T.M., Vreman, H.J., McLaren, D.W., Lewison, L.J., Brown, A.K., and Stevenson, D.K. 1995. Glucose-6-phosphate dehydrogenase deficiency and carboxyhemoglobin concentrations associated with bilirubin-related morbidity and death in Nigerian infants. J. Pediatr. 126: 102-108.
33. Stevenson, D.K., Rodgers, P.A., and Vreman, H.J. 1989. The use of metalloporphyrins for the chemoprevention of neonatal jaundice. Am. J. Dis. Child. 143: 353-356.
34. Stevenson, D.K., Vreman, H.J., Oh, W., Fanaroff, A.A., Wright, L.L., Lemons, J.A., Verter, J., Shankaran, S., Tyson, J.E., Korones, S.B., Bauer, C.R., Stoll, B.J., Papile, L.-A., Donovan, E.F., Ehrenkranz, R.A., and the NICHD Cooperative Multicenter Network of Neonatal Intensive Care Units. 1994. Bilirubin production in healthy term infants as measured by carbon monoxide in breath. Clin. Chem. 40: 1934-1939.
35. Stocker, R., Yamamoto, Y., McDonagh, A.F., Glazer, A.N., and Ames, B.N. 1987. Bilirubin is an antioxidant of possible physiological importance. Science (Washington, D.C.), 235: 1043-1046.
36. Tenhunen, R., Marver, H.S., and Schmid, R. 1969. Microsomal heme oxygenase. Characterization of the enzyme. J. Biol. Chem. 244: 6388-6394.
37. Trakshel, G.M., Sluss, P.M., and Maines, M.D. 1992. Comparative effects of tin- and zinc-protoporphyrin on steroidogenesis: tin-protoporphyrin is a potent inhibitor of cytochrome P-450-dependent activities in the rat adrenals. Pediatr. Res. 31: 196-201.
38. Valaes, T., Petmezaki, S., Henschke, C., Drummond, G.S., and Kappas, A. 1994. Control of jaundice in preterm newborns by an inhibitor of bilirubin production: studies with tin-mesoporphyrin. Pediatrics, 93: 1-11.
39. Vallier, H.A., Rodgers, P.A., Castillo, R.O., and Stevenson, D.K. 1991a. Absorption of zinc deuteroporphyrin 2,4 bis glycol by the neonatal rat small intestine in vivo. Dev. Pharmacol. Ther. 17: 109-115.
40. Vallier, H.A., Rodgers, P.A., and Stevenson, D.K. 1991b. Oral administration of zinc deuteroporphyrin 2,4 bis glycol inhibits heme oxygenase in neonatal rats. Dev. Pharmacol. Ther. 17: 220-222.
41. Verma, A., Hirsch, D.J., Glatt, C.E., Ronnett, G.V., and Snyder, S.H. 1993. Carbon monoxide: a putative neural messenger. Science (Washington, D.C.), 259: 381-384.
42. Vreman, H.J., and Stevenson, D.K. 1988. Heme oxygenase activity as measured by carbon monoxide production. Anal. Biochem. 168: 31-38.
43. Vreman, H.J., Gillman, M.J., Downum, K.R., and Stevenson, D.K. 1990. In vitro generation of carbon monoxide from organic molecules and synthetic metalloporphyrins mediated by light. Dev. Pharmacol. Ther. 15: 112-124.
44. Vreman, H.J., Lee, O.K., and Stevenson, D.K. 1991. In vitro and in vivo characteristics of a heme oxygenase inhibitor: ZnBG. Am. J. Med. Sci. 302: 335-341.
45. Vreman, H.J., Ekstrand, B.C., and Stevenson, D.K. 1993. Selection of metalloporphyrin heme oxygenase inhibitors based on potency and photoreactivity. Pediatr. Res. 33: 195-200.
46. Vreman, H.J., Stevenson, D.K., Oh, W., Fanaroff, A.A., Wright, L.L., Lemons, J.A., Verter, J., Shankaran, S., Tyson, J.E., Korones, S.B., Bauer, C.R., Stoll, B.J., Papile, L.-A., Donovan, E.F., and Ehrenkranz, P.A. 1994. Semi-portable, electrochemical instrument for determining carbon monoxide in breath. Clin. Chem. 40: 1927-1933.
47. Vreman, H.J., Baxter, L.M., Stone, R.T., and Stevenson, D.K. 1996. Evaluation of a fully automated end-tidal carbon monoxide instrument for breath analysis. Clin. Chem. 42: 50-56.